154 related articles for article (PubMed ID: 9881911)
1. Gonadotropin-releasing hormone-induced elevation of serum hCG in choriocarcinoma: a case report.
Furuhashi M; Miyabe Y; Katsumata Y; Oda H; Imai N
Endocr J; 1998 Aug; 45(4):585-90. PubMed ID: 9881911
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
3. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
Yuen BH; Cannon W; Benedet JL; Boyes DA
Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
[TBL] [Abstract][Full Text] [Related]
4. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
5. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
6. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
Braun P; Leyendecker G
Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
[No Abstract] [Full Text] [Related]
7. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
9. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
10. Correlation levels of serum placental growth factor and human chorionic gonadotropin in gestational trophoblastic disease patients.
Oranratanaphan S; Wongwathanavikrom R; Lertkhachonsuk R
J Reprod Med; 2011; 56(7-8):333-8. PubMed ID: 21838164
[TBL] [Abstract][Full Text] [Related]
11. [HCG in patients with hydatidiform mole or chorionepithelioma].
Rjosk HK; Gokel JM; Holzmann K
Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
[No Abstract] [Full Text] [Related]
12. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
13. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
14. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
Nishimura R; Ashitaka Y; Tojo S
Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
[TBL] [Abstract][Full Text] [Related]
15. Choriocarcinoma following ovarian hydatidiform mole: a case report.
Joneborg U; Papadogiannakis N; Lindell G; Marions L
J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
[TBL] [Abstract][Full Text] [Related]
16. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
18. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
Huang SC; Hsieh CY; Ouyang PC
J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
[TBL] [Abstract][Full Text] [Related]
19. Natural history of hydatidiform mole after primary evacuation.
Lurain JR; Brewer JI; Torok EE; Halpern B
Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
[TBL] [Abstract][Full Text] [Related]
20. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
Kato K; Mostafa MH; Mann K; Schindler AE; Hoermann R
Gynecol Endocrinol; 2004 May; 18(5):269-77. PubMed ID: 15346663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]